Computer-based screening of veterans for metabolic syndrome

Metabolic Syndrome and Related Disorders

Volumn 7, Issue 6, 2009, Pages 557-561

  Keane, Jessica ^a,b   Meier, Joy L ^a   Noth, Robert H ^a,b   Swislocki, Arthur L M ^a,b  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FENOFIBRATE; GEMFIBROZIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SMEAR; BODY MASS; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; DIET RESTRICTION; ELECTRONIC MEDICAL RECORD; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SCREENING; STANDARD; UNITED STATES; VETERAN; WAIST CIRCUMFERENCE;

ADULT; AGED; CALIFORNIA; COHORT STUDIES; DATABASES, FACTUAL; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 73649125527     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2009.0021     Document Type: Article

References (35)

1. Meigs JB, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-2167.
2. Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735-2752. (Pubitemid 41532612)
4. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005;28:1769-1778
5. Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: Prevalence and prediction of cardiovascular events. Diabetes Care 2005;28:882-887.
6. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classifi cation of diabetes mellitus and its complications. Part I. Diagnosis and classifi cation of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
8. Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006;83:47-51.
9. Farin HM, Abbasi F, Reaven GM. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 2006;98:1053-1056.
10. Farin HM, Abbasi F, Reaven GM. Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism 2005;54:1323-1328.
11. Ryan MC, Fenster Farin HM, Abbasi F, Reaven GM. Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease. Am J Cardiol 2008;102:40-46.
12. Straker D, Correll CU, Kramer-Ginsberg E, Abdulhamid N, Koshy F, Rubens E, Saint-Vil R, Kane JM, Manu P. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. Am J Psychiatry 2005:162:1217-1221.
13. Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim J-M, Kim I-S, Lee S-K, Oyunsuren T, Yamane Y. Prevalence of the metabolic syndrome using the modifi ed ATP III Definitions for workers in Japan, Korea, and Mongolia. J Occup Health 2005;47:126-135.
14. Kim HM, Kim DJ, Jung IH, Park C, Park J. Prevalence of the metabolic syndrome among Korean adults using the new International Diabetes Federation Definition and the new abdominal obesity criteria for the Korean people. Diabetes Res Clin Pract 2007;77:99-106.
15. Guize L, Thomas F, Pannier B, Bean K, Danchin N, Benetos A. [Metabolic syndrome: Prevalence, risk factors and mortality in a French population of 62 000 subjects] Bull Acad Natl Med 2006;190:685-697; discussion 697-700.
16. The DECODE Study Group, Qiao Q. Comparison of different Definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006;49:2837-2846.
17. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F, Bolondi L, Patterson C. Metabolic Syndrome: Prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006;29:2471-2476.
18. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care 2007;30:8-13.
19. Swislocki ALM, Lin K, Cogburn D, Fann KY, Khuu DT, Noth RH. Postmarketing analysis of lovastatin use in the VA Northern California System of Clinics: A retrospective, computer-based study. Am J Managed Care 1997;3:1537-1545.
20. Swislocki ALM, Khuu Q, Liao E, Wu E, Beza F, Lopez J, Kwan G, Noth RH. Safety and efficacy of metformin in a restricted formulary. Am J Man Care 1999;5:62-68.
21. Meier JL, Swislocki ALM, Lopez JR, Noth RH, Bartlebaugh P Siegel D. Reduction in self-monitoring of blood glucose (SMBG) in persons with Type 2 diabetics resulting in cost savings and no change in glycemic control. Am J Managed Care 2002;8:557-565.
22. Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. Blood pressure control in a diabetic population assessed by computer review. J Hum Hypertens 2006;20:540-542.
23. Snedecor GW, Cochran WG. Statistical Methods, 8th ed. Ames, IA: Iowa State University Press, 1989.
24. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350. (Pubitemid 32378388)
25. Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Race and sex differences in mortality following fracture of the hip. Am J Public Health 1992;82:1147-1150.
26. Ford ES, Abbasi F, Reaven GM. Prevalence of insulin resistance and the metabolic syndrome with alternative Definitions of impaired fasting glucose. Atherosclerosis 2005:181:143-148.
27. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. Diabetes Care 2005;28:1769-1778.
28. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed Definitions. Diabetes Care 2003;26:575-581.
29. Hall WD, Clark LT, Wenger NK, Wright JT Jr, Kumanyika SK, Watson K, Horton EW, Flack JM, Ferdinand KC, Gavin JR 3rd, Reed JW, Saunders E, O'Neal W Jr, African-American Lipid and Cardiovascular Council. The Metabolic Syndrome in African Americans: A review. Ethn Dis 2003;13:414-428.
30. Howard BV, Mayer-Davis EJ, Goff D, Zaccaro DJ, Laws A, Robbins DC, Saad MF, Selby J, Hamman RF, Krauss RM, Haffner SM. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Metabolism 1998;47:1174-1179.
31. Lteif AA, Han K, Mather KJ. Obesity, insulin resistance, and the metabolic syndrome: Determinants of endothelial dysfunction in whites and blacks. Circulation 2005;112:32-38.
32. Loucks EB, Rehkopf DH, Thurston RC, Kawachi I. Socioeconomic disparities in metabolic syndrome differ by gender: Evidence from NHANES III. Ann Epidemiol 2007;17:19-26.
33. Ford ES. Rarer than a blue moon: The use of a diagnostic code for the metabolic syndrome in the U.S. Diabetes Care 2005;28:1808-1809.
34. Reynolds K, Muntner P, Fonseca V. Editorial. Metabolic syndrome: Underrated or underdiagnosed. Diabetes Care 2005;28: 1831-1832.
35. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-1247.